These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18006097)

  • 1. Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
    Folkvord S; Flatmark K; Seierstad T; Røe K; Rasmussen H; Ree AH
    Radiother Oncol; 2008 Mar; 86(3):428-34. PubMed ID: 18006097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines.
    Atallah D; Marsaud V; Radanyi C; Kornprobst M; Rouzier R; Elias D; Renoir JM
    Int J Hyperthermia; 2004 Jun; 20(4):405-19. PubMed ID: 15204521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line.
    Kjellström J; Kjellén E; Johnsson A
    Acta Oncol; 2005; 44(7):687-93. PubMed ID: 16227158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases.
    Kornmann M; Fakler H; Butzer U; Beger HG; Link KH
    Anticancer Res; 2000; 20(5A):3259-64. PubMed ID: 11062751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin resistance induced by ERCC1 up-regulation is abrogated by siRNA-mediated gene silencing in human colorectal cancer cells.
    Seetharam RN; Sood A; Basu-Mallick A; Augenlicht LH; Mariadason JM; Goel S
    Anticancer Res; 2010 Jul; 30(7):2531-8. PubMed ID: 20682979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin activity in selected and unselected human ovarian and colorectal cancer cell lines.
    Noordhuis P; Laan AC; van de Born K; Losekoot N; Kathmann I; Peters GJ
    Biochem Pharmacol; 2008 Jul; 76(1):53-61. PubMed ID: 18508032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib and radiation: a promising combination in colorectal cancer.
    Suen AW; Galoforo S; Marples B; McGonagle M; Downing L; Martinez AA; Robertson JM; Wilson GD
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):213-20. PubMed ID: 20708486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
    Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemo-radio-gene therapy for colorectal cancer cells using Escherichia coli uracil phosphoribosyltransferase gene.
    Koyama F; Fujii H; Mukogawa T; Ueno M; Hamada H; Ishikawa H; Doi S; Nakao T; Matsumoto H; Shimatani H; Takeuchi T; Nakajima Y
    Anticancer Res; 2003; 23(2B):1343-8. PubMed ID: 12820392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining radiation with oxaliplatin: a review of experimental results.
    Hermann RM; Rave-Fränk M; Pradier O
    Cancer Radiother; 2008 Jan; 12(1):61-7. PubMed ID: 18243751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.
    Tanaka R; Ariyama H; Qin B; Takii Y; Baba E; Mitsugi K; Harada M; Nakano S
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.
    Ojima E; Inoue Y; Watanabe H; Hiro J; Toiyama Y; Miki C; Kusunoki M
    Oncol Rep; 2006 Nov; 16(5):1085-91. PubMed ID: 17016597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing securin and p53 protein expression in the oxaliplatin-induced cytotoxicity of human colorectal cancer cells.
    Chiu SJ; Hsu TS; Chao JI
    Toxicol Lett; 2006 Dec; 167(2):122-30. PubMed ID: 17045763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumour effect of raltitrexed and 5-fluorouracil plus folinic acid combination in human cancer cells.
    Avallone A; Di Gennaro E; Bruzzese F; Laus G; Delrio P; Caraglia M; Pepe S; Comella P; Budillon A
    Anticancer Drugs; 2007 Aug; 18(7):781-91. PubMed ID: 17581300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines.
    William-Faltaos S; Rouillard D; Lechat P; Bastian G
    Anticancer Res; 2006; 26(3A):2093-9. PubMed ID: 16827150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell cycle arrest by oxaliplatin on cancer cells.
    William-Faltaos S; Rouillard D; Lechat P; Bastian G
    Fundam Clin Pharmacol; 2007 Apr; 21(2):165-72. PubMed ID: 17391289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of the gene expression profiles of colorectal cancer cell lines in relation to oxaliplatin and cisplatin cytotoxicity.
    Meynard D; Le Morvan V; Bonnet J; Robert J
    Oncol Rep; 2007 May; 17(5):1213-21. PubMed ID: 17390068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells.
    Spagnoletti G; Li Bergolis V; Piscazzi A; Giannelli F; Condelli V; Sisinni L; Bove G; Storto G; Landriscina M
    Tumour Biol; 2018 Apr; 40(4):1010428318770957. PubMed ID: 29663854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination effects of SC144 and cytotoxic anticancer agents.
    Oshima T; Cao X; Grande F; Yamada R; Garofalo A; Louie S; Neamati N
    Anticancer Drugs; 2009 Jun; 20(5):312-20. PubMed ID: 19322070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.